Tomas Blomquist
Director/Board Member at NOLATO AB
Net worth: 495 757 $ as of 2024-03-30
Profile
Tomas Blomquist is currently working as a Director at Nolato AB since 2021.
Prior to this, he worked as the President & Chief Executive Officer at Biotage AB from 2019 to 2024.
He also worked as a Director at Abbott Rapid Diagnostics Ltd.
from 2015 to 2019.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
BIOTAGE AB
0.04% | 2023-07-17 | 29,142 ( 0.04% ) | 495 757 $ | 2024-03-30 |
Tomas Blomquist active positions
Companies | Position | Start |
---|---|---|
NOLATO AB | Director/Board Member | 2020-12-31 |
Former positions of Tomas Blomquist
Companies | Position | End |
---|---|---|
BIOTAGE AB | Chief Executive Officer | 2024-01-03 |
Abbott Rapid Diagnostics Ltd.
Abbott Rapid Diagnostics Ltd. Miscellaneous Commercial ServicesCommercial Services Abbott Rapid Diagnostics Ltd. provides global diagnostics and health management services. It offers diagnostic products and health screening services for healthcare providers to perform diagnostic testing in clinics, communities, hospitals, or homes and rapid diagnostics solutions for cardiovascular disease, infectious disease, drugs of abuse, oncology and women's health. The firm provides products and solutions in the areas of biochemistry, cardiology, community nursing, critical care, diabetes, emergency medicine, general practice, microbiology, NHS health check, pharmacy, primary care, research and women's health services. The company is headquartered in Stockport, United Kingdom. | Director/Board Member | 2019-08-25 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
NOLATO AB | Electronic Technology |
BIOTAGE AB | Health Technology |
Private companies | 1 |
---|---|
Abbott Rapid Diagnostics Ltd.
Abbott Rapid Diagnostics Ltd. Miscellaneous Commercial ServicesCommercial Services Abbott Rapid Diagnostics Ltd. provides global diagnostics and health management services. It offers diagnostic products and health screening services for healthcare providers to perform diagnostic testing in clinics, communities, hospitals, or homes and rapid diagnostics solutions for cardiovascular disease, infectious disease, drugs of abuse, oncology and women's health. The firm provides products and solutions in the areas of biochemistry, cardiology, community nursing, critical care, diabetes, emergency medicine, general practice, microbiology, NHS health check, pharmacy, primary care, research and women's health services. The company is headquartered in Stockport, United Kingdom. | Commercial Services |
- Stock Market
- Insiders
- Tomas Blomquist